In-vitro activity of nisin against clinical isolates of Clostridium difficile

Journal of Chemotherapy
A BartoloniF Paradisi

Abstract

Nisin is a cationic peptide produced by Lactococcus lactis. Its activity against clinical isolates of Clostridium difficile was compared to that of vancomycin and metronidazole by minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and time-kill studies. Nisin was more active than the other agents, with a MIC90 of 0.256 mg/L and strong bactericidal activity. Nisin may be a promising agent for the management of C. difficile associated diarrhea.

References

Oct 1, 1992·The Journal of Hospital Infection·M H Wilcox, R C Spencer
Jun 1, 1983·Journal of Clinical Microbiology·T L SellF R Fekety
Apr 5, 1997·Lancet·K G KerrM H Wilcoy
May 29, 1999·Antimicrobial Agents and Chemotherapy·R E Hancock, D S Chapple

❮ Previous
Next ❯

Citations

May 4, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mary C ReaColin Hill
Jun 5, 2013·Antimicrobial Agents and Chemotherapy·Tiaan D J HeunisLeon M T Dicks
Dec 14, 2011·Journal of Clinical Microbiology·Mary C ReaColin Hill
Oct 11, 2014·International Journal of Molecular Sciences·Ana Maria Carmona-Ribeiro, Letícia Dias de Melo Carrasco
Dec 19, 2015·Journal of Applied Microbiology·J M ShinY L Kapila
Sep 24, 2016·Journal of Clinical Medicine·Eamonn P Culligan, Roy D Sleator
Nov 12, 2015·Journal of Medical Microbiology·Christophe Le LayIsmaı L Fliss
Mar 28, 2017·Canadian Journal of Microbiology·Changhoon ChaiSe-Wook Oh
Apr 5, 2013·The American Journal of Gastroenterology·Ahmad H AliRoger D Smalligan
Sep 29, 2018·Surgical Infections·Donald E Fry
Nov 28, 2018·Expert Opinion on Drug Discovery·Stephanie Kate Sandiford
Jun 1, 2010·Journal of Pediatric Gastroenterology and Nutrition·Sushrut Jangi, J Thomas Lamont
Mar 21, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·James FlynnSarah P Hudson
Jun 20, 2007·Journal of Medical Microbiology·Mary C ReaColin Hill
Nov 28, 2012·Biochemical Society Transactions·Evelyn M MolloyColin Hill
Mar 4, 2020·Current Topics in Medicinal Chemistry·Jiarui LiEster Boix
Feb 27, 2018·Gastroenterology Report·Roy J Hopkins, Robert B Wilson
Apr 26, 2018·Frontiers in Microbiology·Holger Schäffler, Anne Breitrück
Sep 20, 2018·Probiotics and Antimicrobial Proteins·Angélique LewiesJohannes F Wentzel
Sep 26, 2020·Frontiers in Microbiology·Santosh Kumar TiwariMichael L Chikindas
Oct 13, 2015·Acta Crystallographica. Section F, Structural Biology Communications·Sakshi KhosaSander H J Smits
Oct 17, 2018·Frontiers in Microbiology·Leon M T DicksAnton D van Staden
Jun 16, 2017·Annual Review of Microbiology·Brittany B Lewis, Eric G Pamer
Oct 13, 2020·Frontiers in Bioengineering and Biotechnology·Svetoslav D TodorovWilhelm H Holzapfel
Jan 7, 2021·Probiotics and Antimicrobial Proteins·Haodan ZhuKongwang He
Nov 23, 2018·Journal of Colloid and Interface Science·James FlynnSarah P Hudson
Dec 29, 2020·Critical Reviews in Food Science and Nutrition·Silpa S, Rupachandra S
Mar 12, 2021·Frontiers in Microbiology·Gabrielle S DijksteelBouke K H L Boekema
Sep 1, 2021·Periodontology 2000·Trang NguyenYvonne Kapila
Jul 8, 2021·Scientific Reports·Christian KranjecDzung B Diep

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.